Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
IJPR-Iranian Journal of Pharmaceutical Research. 2015; 14 (1): 149-157
Dans Anglais | IMEMR | ID: emr-154876

Résumé

Helicobacter pylori infection, the most common chronic bacterial infection in the world, and an important cause of gastrointestinal disorders, may be involved in the pathogenesis of some extra-gastrointestinal disturbances, as well as an increase in blood levels of certain inflammatory markers. Anti-bacterial activity against Helicobacter pylori and anti-inflammatory properties of omega-3 fatty acids have been studied in several research studies. The purpose of the present study was the comparison of the effects of Eicosapentaenoic Acid and Docosahexaenoic Acid supplementation on Helicobacter pylori eradication, serum levels of some inflammatory markers and total antioxidant capacity. In a randomized, double-blind, placebo-controlled clinical trial, 97 Helicobacter pylori positive patients [64 patients in the two intervention groups and 33 in the control group], received 2 grams daily of Eicosapentaenoic Acid, Docosahexaenoic Acid or Medium Chain Triglyceride oil as placebo, along with conventional tetra-drug Helicobacter pylori eradication regimen, for 12 weeks. Helicobacter pylori eradication test and measurement of concentration of interleukine-6, interleukine-8, high-sensitivity C-reactive protein and total antioxidant capacity were performed after the intervention. There was no significant difference in eradication rate of the infection, levels of interleukine-6 and total antioxidant capacity among the three groups, while the levels of interleukine-8 and high-sensitivity C-reactive protein were statistically different. Eicosapentaenoic Acid or Docosahexaenoic Acid supplementation had no significant differential impact on the eradication of Helicobacter pylori infection, and serum levels of interleukine-6 and total antioxidant capacity. However, it had a desirable effect on the levels of interleukine-8 and high-sensitivity C-reactive protein in Helicobacter pylori positive patients


Sujets)
Humains , Femelle , Mâle , Helicobacter pylori , Acide eicosapentanoïque/pharmacologie , Acide docosahexaénoïque/pharmacologie , Inflammation , Antioxydants , Méthode en double aveugle , Interleukine-6 , Interleukine-8 , Protéine C-réactive
2.
Braz. j. med. biol. res ; 46(8): 696-699, ago. 2013. graf
Article Dans Anglais | LILACS | ID: lil-684534

Résumé

We investigated the effect of fish oil (FO) supplementation on tumor growth, cyclooxygenase 2 (COX-2), peroxisome proliferator-activated receptor gamma (PPARγ), and RelA gene and protein expression in Walker 256 tumor-bearing rats. Male Wistar rats (70 days old) were fed with regular chow (group W) or chow supplemented with 1 g/kg body weight FO daily (group WFO) until they reached 100 days of age. Both groups were then inoculated with a suspension of Walker 256 ascitic tumor cells (3×107 cells/mL). After 14 days the rats were killed, total RNA was isolated from the tumor tissue, and relative mRNA expression was measured using the 2-ΔΔCT method. FO significantly decreased tumor growth (W=13.18±1.58 vs WFO=5.40±0.88 g, P<0.05). FO supplementation also resulted in a significant decrease in COX-2 (W=100.1±1.62 vs WFO=59.39±5.53, P<0.001) and PPARγ (W=100.4±1.04 vs WFO=88.22±1.46, P<0.05) protein expression. Relative mRNA expression was W=1.06±0.022 vs WFO=0.31±0.04 (P<0.001) for COX-2, W=1.08±0.02 vs WFO=0.52±0.08 (P<0.001) for PPARγ, and W=1.04±0.02 vs WFO=0.82±0.04 (P<0.05) for RelA. FO reduced tumor growth by attenuating inflammatory gene expression associated with carcinogenesis.


Sujets)
Animaux , Mâle , /génétique , Prolifération cellulaire/effets des médicaments et des substances chimiques , /génétique , Huiles de poisson/pharmacologie , Récepteur PPAR gamma/génétique , Facteur de transcription RelA/génétique , /métabolisme , Compléments alimentaires , Acide docosahexaénoïque/pharmacologie , Acide eicosapentanoïque/pharmacologie , Huiles de poisson/composition chimique , Inhibiteurs de croissance/pharmacologie , Immunotransfert , Rat Wistar , Réaction de polymérisation en chaine en temps réel , Transcription génétique/effets des médicaments et des substances chimiques
3.
Journal of Forensic Medicine ; (6): 454-459, 2010.
Article Dans Chinois | WPRIM | ID: wpr-983613

Résumé

The relationship between omega-3 polyunsaturated fatty acids (PUFAs) and violent-aggressive behavior has been payed attention since 1980s. Their correlation was explored by many epidemiological investigations, and the effect of PUFAs on prevention or reduction of violent-aggressive behavior in different groups were also affirmed by some intervention studies. This article summarized the previous studies and reviewed the history of epidemiological or intervention studies on PUFAs and its relationship with violent-aggressive behavior. It also presented the possible influencing factors in these studies and possible mechanisms.


Sujets)
Animaux , Humains , Agressivité , Matières grasses alimentaires insaturées/pharmacologie , Compléments alimentaires , Acide docosahexaénoïque/pharmacologie , Acide eicosapentanoïque/pharmacologie , Acides gras omega-3/pharmacologie , Acides gras omega-6/pharmacologie , Poissons , Acide folique/métabolisme , Acide 5-hydroxy-indole-3-acétique/métabolisme , Norépinéphrine/métabolisme , Facteurs de risque , Sérotonine/métabolisme , Violence/prévention et contrôle
SÉLECTION CITATIONS
Détails de la recherche